BB Biotech AG Profit Margin

BB Biotech AG (BBAGF) currently reports a profit margin of 490.56% as of September 2026. That compares with -3052.26% in the prior-year period — up 116.1% year over year. That is above the sector sector average of 13.23%. Use the charts on this page to explore BB Biotech AG's profit margin history and peer comparisons.

BB Biotech AG's profit margin increased from -3052.26% to 490.56% — a 116.1% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BB Biotech AG's profit margin of 490.56% is higher than the its sector sector average of 13.23%. That is roughly 3609.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but BB Biotech AG's current 490.56% should be judged against industry norms (sector average: 13.23%) and against BBAGF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 490.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for BB Biotech AG, and consider following BBAGF for alerts when major investors trade the stock.